Assessing the Quality of Life, Coping Strategies, Anxiety and Depression Levels in Patients with Long-COVID-19 Syndrome: A Six-Month Follow-Up Study.
Adrian Vasile BotaFelix BratosinIulia BogdanSusa Septimiu-RaduAdrian Cosmin IlieSonia-Roxana BurticDavid Vladut RazvanRaluca TudorMirela Florica IndriesAndrei Nicolae CsepAriadna Petronela FildanCamelia Melania FizedeanIosif MarincuPublished in: Diseases (Basel, Switzerland) (2024)
This longitudinal study investigates the psychosocial effects of long-COVID Syndrome, a domain still not extensively researched. It specifically evaluates the quality of life, coping mechanisms, anxiety and depression levels in COVID-19 survivors, differentiating between those with and without long-COVID Syndrome. Conducted at the Victor Babes Hospital for Infectious Diseases and Pulmonology in Timisoara, Romania, the study utilized a cohort of patients diagnosed with mild to moderate COVID-19. The following standardized tools: WHOQOL-BREF for quality of life, COPE-60 for coping strategies, and the Hospital Anxiety and Depression Scale (HADS), were employed for the assessment. The sample consisted of 86 patients displaying persistent post-acute symptoms and 432 asymptomatic patients at the 6-month post-discharge mark. Patients with frequent post-acute symptoms reported significantly higher levels of fatigue (8.2 ± 1.4), cognitive difficulties (7.5 ± 1.6), and respiratory challenges (7.8 ± 1.3), along with a markedly lower overall quality of life (7.0 ± 1.5) compared to their asymptomatic counterparts. HADS scores revealed elevated depression (6.8 ± 1.9) and anxiety (7.1 ± 2.3) in the symptomatic group. Quality of life, as evaluated through the use of WHOQOL-BREF, showed lower scores in the symptomatic cohort across physical (58.8 ± 15.8), mental (56.3 ± 16.4), and social domains (50.2 ± 17.5). COPE-60 findings indicated a higher prevalence of disengagement (56.4%) and emotion-focused coping strategies (61.8%) in the symptomatic group, in contrast to 30.1% and 37.0%, respectively, in the asymptomatic group. The study highlights that long-COVID Syndrome significantly deteriorates the quality of life and is associated with increased depression and anxiety levels. The prevalent use of disengagement and emotion-focused coping strategies among patients with persistent symptoms suggests a need for enhanced psychosocial support tailored to this subgroup.
Keyphrases
- coronavirus disease
- sars cov
- depressive symptoms
- end stage renal disease
- mental health
- social support
- healthcare
- ejection fraction
- chronic kidney disease
- newly diagnosed
- liver failure
- respiratory syndrome coronavirus
- sleep quality
- infectious diseases
- randomized controlled trial
- autism spectrum disorder
- magnetic resonance
- young adults
- physical activity
- emergency department
- magnetic resonance imaging
- prognostic factors
- hepatitis b virus
- risk factors
- multidrug resistant
- intensive care unit
- respiratory failure
- patient reported outcomes
- double blind